We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056

News   Oct 30, 2009

 
PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056
 
 
 

RELATED ARTICLES

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Discovery Could Help Treat People With Cardiovascular Disease

News

Researchers have found a link between a peptide called apelin and a reduction of abdominal aortic aneurysms that was shown to dramatically reduce mortality in mice. They are using this knowledge to develop a new medical therapy to treat cardiovascular disease.

READ MORE

Tiny Protein Could Play Huge Role in Treatment of Duchenne Muscular Dystrophy

News

A new multi-institution study suggests a tiny protein could play a major role in combating heart failure related to Duchenne muscular dystrophy, the most common lethal genetic disorder among children.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE